Instructions for authors are shaped on the recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/).

The ethics of The New Journal of Urology have been established in accordance with the guidelines of Committee on Publication Ethics (COPE) (https://doi.org/10.24318/cope.2019.2.24).

The Editorial Board follows to the recommendations of International Committee of Medical Journal Editors (ICJME) for dealing with scientific misconduct, such as falsification of data, plagiarism, improprieties of authorship, violation of generally accepted research practices and redundant publication and duplicate publication.

Originality, high scientific quality and citation potential are the most important criteria for a manuscript to be accepted for publication. Manuscripts submitted for evaluation should not have been previously presented or already published in an electronic or printed medium. Manuscripts that have been presented in a meeting should be submitted with detailed information on the organization, including the name, date, and location of the organization.

An approval of research protocols by the Ethics Committee in accordance with international agreements World Medical Association Declaration of Helsinki ( https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) is required for experimental, clinical, and drug studies and for some case reports.

If required, ethics committee reports or an equivalent official document will be requested from the authors.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them.. https://doi.org/10.24318/cope.2019.2.26

 

Disclosure of Conflicts of Interest

A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence the author's decisions or work on the manuscript. Authors are required to identify all relevant financial interests and relationships or financial conflicts (e.g., employment/affiliation, grants or funding, consultancies, stock ownership or options, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests that represent potential future financial gain. The disclosure of funding should be indicated in the Acknowledgments section within the manuscript.

The “Copyright Agreement and Acknowledgement of Authorship Form” should be completed by the corresponding author on behalf of each coauthor and should be submitted with the manuscript.

The Editorial Board of The New Journal of Urology will immediately reject a submitting manuscript which has a high similarity index to other papers in the Similarity Check. When malpractices are found in the submitted article to The New Journal of Urology, Editorial Board will follow the flowchart by the Committee on Publication Ethics (COPE) for settlement of any misconduct. The Editorial Board of The New Journal of Urology is always willing to publish corrections, clarifications, retractions when needed.

Responsibilities of Author

The Editorial Board of the journal handles all appeal and complaint cases within the scope of Committee on Publication Ethics guidelines (COPE). In such cases, authors should get in direct contact with the editorial office regarding their appeals and complaints. When needed, an ombudsperson may be assigned to resolve cases that cannot be resolved internally. The Editor-in-Chief is the final authority in the decision-making process for all appeals and complaints.

The New Journal of Urolgy requires each submission to be accompanied by Copyright Agreement and Acknowledgement of Authorship Form. When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

• For manuscripts concerning experimental research on humans, a statement should be included that shows that written informed consent of patients and volunteers was obtained following a detailed explanation of the procedures that they may undergo.

• For studies carried out on animals, the measures taken to prevent pain and suffering of the animals should be stated clearly.

• Information on patient consent, the name of the ethics committee, and the ethics committee approval number should also be stated in the Materials and Methods section of the manuscript.

• It is the authors’ responsibility to carefully protect the patients’ anonymity. For photographs that may reveal the identity of the patients, releases signed by the patient or their legal representative should be enclosed.

All submissions are screened by a similarity detection software (iThenticate) and the limitation without similarity is 20%.

Statements or opinions expressed in the manuscripts published in The New Journal of Urology reflect the views of the author(s) and not the opinions of the editors, the editorial board, or the publisher; the editors, the editorial board, and the publisher disclaim any responsibility or liability for such materials. The final responsibility in regard to the published content rests with the authors.

 

Open Access&Deposit Policy

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supporting a greater global exchange of knowledge.

Every paper published in The New Journal of Urology is freely available via the website https://newjournalurology.com/archive .

Open Access Policy is based on rules of Budapest Open Access Initiative (BOAI) http://www.budapestopenaccessinitiative.org/.

Editorial and publication processes of the journal are shaped in accordance with the guidelines of the international organizations such as the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE). Our journal follows the principles of transparency and best practices for scholarly publishing as identified by the Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishing Association (OASPA), and the World Association of Medical Editors (WAME) (doi: 10.24318/cope.2019.1.12).

Deposit Policy

Deposit policy (Self-archiving policy) are as follows:

• Author can archive pre-print (i.e., pre-refereeing);

• Author can archive postprint (i.e., final draft after refereeing);

• and Author can archive publisher's version/PDF.

All published content in The New Journal of Urology are licensed under Creative Commons CC BY Attribution 4.0 International License.

 

Copright&Licensing

Copyright

The New Journal of Urolgy requires each submission to be accompanied by a Copyrıght Agreement and Acknowledgement of Authorship Form. When using previously published content, including figures, tables, or any other material in both print and electronic formats, authors must obtain permission from the copyright holder. Legal, financial and criminal liabilities in this regard belong to the author(s).

The contents can be used as a reference in scientific publications and presentations.

The New Journal of Urology allows the author to retain copyright without restriction.

There is no charge for publishing, or no copyright fee is paid to the authors.

No fee is required for submitting articles, evaluation, processing or publishing process from the authors.

Lisencing

The Eurasian Urooncological Association holds the copyright for all content published in the journal from 2008 to 2023. All published content (2008-2023) in The New Journal of Urology are licensed under the terms of the Creative Commons CC-BY-NC 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/ ).

Under this license, the third parties and authors are allowed to reuse the articles for non-commercial purposes. For commercial use, please contact the Eurasian Urooncology Association using the contact information provided below to obtain necessary permissions.

Address: Eurasian Urooncological Association, Istanbul Cd. Yenimahalle Neigh. Köşk Apt. No:113/A Bakırkoy / Istanbul

Phone: +90 533 726 72 55

Web: www.avrasyauroonkoloji.org

E-mail: dergi@avrasyauroonkoloji.org

By the year 2024 (starting with volume 19) all published content in The New Journal of Urology are licensed under Creative Commons Attribution CC-BY 4.0 International License.

Under this licence, the third parties and authors are free to copy, distribute, transmit, adapt, and even make commercial use of the material, provided the article is properly cited.

If there is any concern or dispute at over the studies, we will follow the flowcharts of Committee on Publication Ethics (COPE) to solve them. https://doi.org/10.24318/cope.2019.2.26

Plagiarism

Definition

When an author tries to present the work of someone else as his or her own, it is called plagiarism. In addition, when an author uses a considerable portion of his or her own previously published work in a new one without properly citing the reference, it is called a duplicate publication; sometimes also referred to as self-plagiarism. This may range from publishing the same article in another journal to 'salami-slicing', which is data segmentation, to adding little new data to the previous article.

Policy

The New Journal of Urology journal uses the Crossref Similarity Check program for scanning plagiarism. The articles to be published are required to have less than 20% similarity. If suspected plagiarism is found in an article either before (by reviewers or editorial team) or after (by readers) publication, the journal will act according to COPE’s code of conduct and flowcharts.  

Nowadays, the use of artificial intelligence in the writing of original research articles is becoming widespread thanks to the developing technological conditions. The author is obliged to follow the ethical standards regarding the use of artificial intelligence in the writing of articles submitted to the New Journal of Urology. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. This may constitute standard plagiarism as the use of AI does not meet the criteria for authorship.

Applying the technology should be done with human oversight and control, and authors should carefully review and edit the result, as AI can generate authoritative-sounding output that can be incorrect, incomplete or biased. AI and AI-assisted technologies should not be listed as an author or co-author, or be cited as an author. The editors and reviewers of the New Journal of Urology are careful to evaluate the text in terms of the use of artificial intelligence tools that can generate references.

Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the writing process. A statement should appear in the published work. Please note that authors are ultimately responsible and accountable for the contents of the work.